Connection

MICHAEL LEWIS to Drug Delivery Systems

This is a "connection" page, showing publications MICHAEL LEWIS has written about Drug Delivery Systems.
Connection Strength

0.229
  1. Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer. J Clin Invest. 2018 04 02; 128(4):1283-1299.
    View in: PubMed
    Score: 0.139
  2. Cisplatin@US-tube carbon nanocapsules for enhanced chemotherapeutic delivery. Biomaterials. 2012 Feb; 33(5):1455-61.
    View in: PubMed
    Score: 0.090
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.